Shares of InVivo Therapeutics (NVIV.OB -17%) plummet after the company says plans to up-list to a national securities exchange have "been postponed indefinitely due to issues related to corporate governance."
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs